Index
1 Drug of Abuse (DOA) Testing Equipment Market Overview
1.1 Product Overview and Scope of Drug of Abuse (DOA) Testing Equipment
1.2 Drug of Abuse (DOA) Testing Equipment Segment by Type
1.2.1 Global Drug of Abuse (DOA) Testing Equipment Market Value Comparison by Type (2024-2030)
1.2.2 Immunoassay Analyzers
1.2.3 Chromatography Instruments
1.2.4 Breath Analyzers
1.2.5 Others
1.3 Drug of Abuse (DOA) Testing Equipment Segment by Application
1.3.1 Global Drug of Abuse (DOA) Testing Equipment Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Workplace
1.3.5 At-Home
1.4 Global Drug of Abuse (DOA) Testing Equipment Market Size Estimates and Forecasts
1.4.1 Global Drug of Abuse (DOA) Testing Equipment Revenue 2019-2030
1.4.2 Global Drug of Abuse (DOA) Testing Equipment Sales 2019-2030
1.4.3 Global Drug of Abuse (DOA) Testing Equipment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug of Abuse (DOA) Testing Equipment Market Competition by Manufacturers
2.1 Global Drug of Abuse (DOA) Testing Equipment Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug of Abuse (DOA) Testing Equipment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug of Abuse (DOA) Testing Equipment Average Price by Manufacturers (2019-2024)
2.4 Global Drug of Abuse (DOA) Testing Equipment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug of Abuse (DOA) Testing Equipment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug of Abuse (DOA) Testing Equipment, Product Type & Application
2.7 Drug of Abuse (DOA) Testing Equipment Market Competitive Situation and Trends
2.7.1 Drug of Abuse (DOA) Testing Equipment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug of Abuse (DOA) Testing Equipment Players Market Share by Revenue
2.7.3 Global Drug of Abuse (DOA) Testing Equipment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug of Abuse (DOA) Testing Equipment Retrospective Market Scenario by Region
3.1 Global Drug of Abuse (DOA) Testing Equipment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug of Abuse (DOA) Testing Equipment Global Drug of Abuse (DOA) Testing Equipment Sales by Region: 2019-2030
3.2.1 Global Drug of Abuse (DOA) Testing Equipment Sales by Region: 2019-2024
3.2.2 Global Drug of Abuse (DOA) Testing Equipment Sales by Region: 2025-2030
3.3 Global Drug of Abuse (DOA) Testing Equipment Global Drug of Abuse (DOA) Testing Equipment Revenue by Region: 2019-2030
3.3.1 Global Drug of Abuse (DOA) Testing Equipment Revenue by Region: 2019-2024
3.3.2 Global Drug of Abuse (DOA) Testing Equipment Revenue by Region: 2025-2030
3.4 North America Drug of Abuse (DOA) Testing Equipment Market Facts & Figures by Country
3.4.1 North America Drug of Abuse (DOA) Testing Equipment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug of Abuse (DOA) Testing Equipment Sales by Country (2019-2030)
3.4.3 North America Drug of Abuse (DOA) Testing Equipment Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drug of Abuse (DOA) Testing Equipment Market Facts & Figures by Country
3.5.1 Europe Drug of Abuse (DOA) Testing Equipment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug of Abuse (DOA) Testing Equipment Sales by Country (2019-2030)
3.5.3 Europe Drug of Abuse (DOA) Testing Equipment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug of Abuse (DOA) Testing Equipment Market Facts & Figures by Country
3.6.1 Asia Pacific Drug of Abuse (DOA) Testing Equipment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug of Abuse (DOA) Testing Equipment Sales by Country (2019-2030)
3.6.3 Asia Pacific Drug of Abuse (DOA) Testing Equipment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drug of Abuse (DOA) Testing Equipment Market Facts & Figures by Country
3.7.1 Latin America Drug of Abuse (DOA) Testing Equipment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug of Abuse (DOA) Testing Equipment Sales by Country (2019-2030)
3.7.3 Latin America Drug of Abuse (DOA) Testing Equipment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug of Abuse (DOA) Testing Equipment Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug of Abuse (DOA) Testing Equipment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug of Abuse (DOA) Testing Equipment Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug of Abuse (DOA) Testing Equipment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Drug of Abuse (DOA) Testing Equipment Sales by Type (2019-2030)
4.1.1 Global Drug of Abuse (DOA) Testing Equipment Sales by Type (2019-2024)
4.1.2 Global Drug of Abuse (DOA) Testing Equipment Sales by Type (2025-2030)
4.1.3 Global Drug of Abuse (DOA) Testing Equipment Sales Market Share by Type (2019-2030)
4.2 Global Drug of Abuse (DOA) Testing Equipment Revenue by Type (2019-2030)
4.2.1 Global Drug of Abuse (DOA) Testing Equipment Revenue by Type (2019-2024)
4.2.2 Global Drug of Abuse (DOA) Testing Equipment Revenue by Type (2025-2030)
4.2.3 Global Drug of Abuse (DOA) Testing Equipment Revenue Market Share by Type (2019-2030)
4.3 Global Drug of Abuse (DOA) Testing Equipment Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug of Abuse (DOA) Testing Equipment Sales by Application (2019-2030)
5.1.1 Global Drug of Abuse (DOA) Testing Equipment Sales by Application (2019-2024)
5.1.2 Global Drug of Abuse (DOA) Testing Equipment Sales by Application (2025-2030)
5.1.3 Global Drug of Abuse (DOA) Testing Equipment Sales Market Share by Application (2019-2030)
5.2 Global Drug of Abuse (DOA) Testing Equipment Revenue by Application (2019-2030)
5.2.1 Global Drug of Abuse (DOA) Testing Equipment Revenue by Application (2019-2024)
5.2.2 Global Drug of Abuse (DOA) Testing Equipment Revenue by Application (2025-2030)
5.2.3 Global Drug of Abuse (DOA) Testing Equipment Revenue Market Share by Application (2019-2030)
5.3 Global Drug of Abuse (DOA) Testing Equipment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Siemens AG
6.1.1 Siemens AG Corporation Information
6.1.2 Siemens AG Description and Business Overview
6.1.3 Siemens AG Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Siemens AG Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.1.5 Siemens AG Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Bio-Rad
6.5.1 Bio-Rad Corporation Information
6.5.2 Bio-Rad Description and Business Overview
6.5.3 Bio-Rad Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bio-Rad Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.5.5 Bio-Rad Recent Developments/Updates
6.6 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Abbott Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.6.5 Abbott Recent Developments/Updates
6.7 Quest Diagnostics
6.6.1 Quest Diagnostics Corporation Information
6.6.2 Quest Diagnostics Description and Business Overview
6.6.3 Quest Diagnostics Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Quest Diagnostics Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.7.5 Quest Diagnostics Recent Developments/Updates
6.8 Psychemedics
6.8.1 Psychemedics Corporation Information
6.8.2 Psychemedics Description and Business Overview
6.8.3 Psychemedics Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Psychemedics Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.8.5 Psychemedics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug of Abuse (DOA) Testing Equipment Industry Chain Analysis
7.2 Drug of Abuse (DOA) Testing Equipment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug of Abuse (DOA) Testing Equipment Production Mode & Process
7.4 Drug of Abuse (DOA) Testing Equipment Sales and Marketing
7.4.1 Drug of Abuse (DOA) Testing Equipment Sales Channels
7.4.2 Drug of Abuse (DOA) Testing Equipment Distributors
7.5 Drug of Abuse (DOA) Testing Equipment Customers
8 Drug of Abuse (DOA) Testing Equipment Market Dynamics
8.1 Drug of Abuse (DOA) Testing Equipment Industry Trends
8.2 Drug of Abuse (DOA) Testing Equipment Market Drivers
8.3 Drug of Abuse (DOA) Testing Equipment Market Challenges
8.4 Drug of Abuse (DOA) Testing Equipment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer